PL357301A1 - Kompozycje farmaceutyczne, zawierające oligosacharydy, nowe oligosacharydy i ich wytwarzanie - Google Patents

Kompozycje farmaceutyczne, zawierające oligosacharydy, nowe oligosacharydy i ich wytwarzanie

Info

Publication number
PL357301A1
PL357301A1 PL01357301A PL35730101A PL357301A1 PL 357301 A1 PL357301 A1 PL 357301A1 PL 01357301 A PL01357301 A PL 01357301A PL 35730101 A PL35730101 A PL 35730101A PL 357301 A1 PL357301 A1 PL 357301A1
Authority
PL
Poland
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
containing oligosaccharides
oligosaccharides
Prior art date
Application number
PL01357301A
Other languages
English (en)
Other versions
PL204419B1 (pl
Inventor
Pierre Mourier
Elisabeth Perrin
Christian Viskov
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of PL357301A1 publication Critical patent/PL357301A1/pl
Publication of PL204419B1 publication Critical patent/PL204419B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
PL357301A 2000-03-28 2001-03-26 Kompozycja farmaceutyczna, oligosacharyd, sposób wytwarzania oligosacharydu i zastosowanie oligosacharydu PL204419B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0003910A FR2807043B1 (fr) 2000-03-28 2000-03-28 Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation
PCT/FR2001/000903 WO2001072762A1 (fr) 2000-03-28 2001-03-26 Compositions pharmaceutiques contenant des oligosaccharides et leur preparation

Publications (2)

Publication Number Publication Date
PL357301A1 true PL357301A1 (pl) 2004-07-26
PL204419B1 PL204419B1 (pl) 2010-01-29

Family

ID=8848572

Family Applications (1)

Application Number Title Priority Date Filing Date
PL357301A PL204419B1 (pl) 2000-03-28 2001-03-26 Kompozycja farmaceutyczna, oligosacharyd, sposób wytwarzania oligosacharydu i zastosowanie oligosacharydu

Country Status (26)

Country Link
EP (1) EP1272499B1 (pl)
JP (1) JP2003529570A (pl)
KR (1) KR20030001394A (pl)
CN (1) CN1183149C (pl)
AR (1) AR034251A1 (pl)
AT (1) ATE290543T1 (pl)
AU (1) AU782713B2 (pl)
BR (1) BR0109617A (pl)
CA (1) CA2403906A1 (pl)
DE (1) DE60109279T2 (pl)
EA (1) EA004768B1 (pl)
EE (1) EE200200551A (pl)
ES (1) ES2236206T3 (pl)
FR (1) FR2807043B1 (pl)
HU (1) HUP0300330A3 (pl)
IL (1) IL151832A0 (pl)
ME (1) MEP88408A (pl)
MX (1) MXPA02009455A (pl)
NO (1) NO20024590D0 (pl)
NZ (1) NZ521558A (pl)
PL (1) PL204419B1 (pl)
PT (1) PT1272499E (pl)
SK (1) SK286745B6 (pl)
WO (1) WO2001072762A1 (pl)
YU (1) YU72802A (pl)
ZA (1) ZA200207707B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750207B1 (en) * 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US20050186679A1 (en) * 2004-02-24 2005-08-25 Christian Viskov Method for determining specific groups constituting heparins or low molecular weight heparins
JP5116071B2 (ja) 2005-07-20 2013-01-09 帝國製薬株式会社 Ｄ−アロースおよびｄ−プシコースの抗神経因性疼痛効果の利用
JP5137118B2 (ja) 2005-08-30 2013-02-06 国立大学法人高知大学 ユニバーサル塩基
EP3418287A1 (en) * 2017-06-21 2018-12-26 Universität für Bodenkultur Wien Chemical release of asparaginelinked glycans
CN115317507A (zh) * 2022-09-19 2022-11-11 中国科学院海洋研究所 低分子量褐藻多糖硫酸酯在制备抗多动症药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases

Also Published As

Publication number Publication date
DE60109279T2 (de) 2006-04-13
JP2003529570A (ja) 2003-10-07
EA004768B1 (ru) 2004-08-26
EP1272499A1 (fr) 2003-01-08
ZA200207707B (en) 2003-12-24
SK286745B6 (sk) 2009-04-06
NZ521558A (en) 2005-10-28
PT1272499E (pt) 2005-06-30
NO20024590L (no) 2002-09-25
WO2001072762A1 (fr) 2001-10-04
PL204419B1 (pl) 2010-01-29
BR0109617A (pt) 2003-02-04
MEP88408A (en) 2011-12-20
KR20030001394A (ko) 2003-01-06
AU782713B2 (en) 2005-08-25
SK13932002A3 (sk) 2003-06-03
HUP0300330A2 (hu) 2003-06-28
AU4663901A (en) 2001-10-08
EE200200551A (et) 2004-04-15
CN1183149C (zh) 2005-01-05
NO20024590D0 (no) 2002-09-25
MXPA02009455A (es) 2003-02-12
DE60109279D1 (de) 2005-04-14
FR2807043B1 (fr) 2002-11-22
CN1426419A (zh) 2003-06-25
HUP0300330A3 (en) 2003-09-29
IL151832A0 (en) 2003-04-10
EP1272499B1 (fr) 2005-03-09
CA2403906A1 (fr) 2001-10-04
EA200201024A1 (ru) 2003-02-27
AR034251A1 (es) 2004-02-18
FR2807043A1 (fr) 2001-10-05
ATE290543T1 (de) 2005-03-15
HK1056564A1 (en) 2004-02-20
YU72802A (sh) 2006-01-16
ES2236206T3 (es) 2005-07-16

Similar Documents

Publication Publication Date Title
DZ3311A1 (fr) Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation
DZ3313A1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en) Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0300207A3 (en) 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
IL151912A0 (en) Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them
HUP0303184A3 (en) Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them
HUP0200747A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0303204A3 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing them
IL151832A0 (en) Pharmaceutical compositions containing oligosaccharides and preparation thereof
HUP0300557A3 (en) N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
HUP0201443A3 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them
GB0013503D0 (en) Pharmaceutical compositions and their uses
HUP0303688A3 (en) Propanolaminotetralines, preparation thereof and pharmaceutical compositions containing same
IL135707A0 (en) 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
SI1272499T1 (en) Pharmaceutical compositions containing oligosaccharides and preparation thereof
GB0000001D0 (en) Pharmaceutical compositions and their preparation
IL156032A0 (en) Spiroindene derivatives and pharmaceutical compositions containing the same
HUP0203182A3 (en) Diaryl-enynes pharmaceutical compositions containing them and their use